Type your tag names separated by a space and hit enter

Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM)

Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

Slawson, David C., et al., editors. "Alirocumab Has Minimal Net Benefit for Patients With Hyperlipidemia (ODYSSEY LONG TERM)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_.
Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM). In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_. Accessed March 25, 2019.
Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM). (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_
Alirocumab Has Minimal Net Benefit for Patients With Hyperlipidemia (ODYSSEY LONG TERM) [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 March 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM) ID - 428328 ED - Slawson,David C, ED - Shaughnessy,Allen F, ED - Ebell,Mark H, ED - Barry,Henry, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -